MCI’s 2019 FRA is open for submission. This funding will support research in reversible, non-hormonal male contraceptive discovery and development. MCI intends to fund up to five grants, ranging from $150,000 to $300,000 over two years. MCI’s Priority Research Areas include:
Post-meiotic phase of spermatogenesis
Sperm functions required for normal fertilization, such as sperm motility and the acrosome reaction
Post-testicular processes required for fertility, including epididymal maturation and sperm transport in the excurrent ducts
Other processes that lead to fast-acting, reversible male contraceptives
The potential for Multipurpose Prevention Technology (MPT) products acting against sexually transmitted infections
Application are due by May 31, 2019. Additional information and the application can be found here.